Prevalence of Pre-Diabetes and Its Association With Clustering of Cardiometabolic Risk Factors and Hyperinsulinemia Among U.S. Adolescents

OBJECTIVE—Impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT) are considered to constitute “pre-diabetes.” We estimated the prevalence of IFG, IGT, and pre-diabetes among U.S. adolescents using data from a nationally representative sample. RESEARCH DESIGN AND METHODS—We analyzed data from participants aged 12–19 years in the National Health and Nutrition Examination Survey 2005–2006. We used fasting plasma glucose and 2-h glucose during an oral glucose tolerance test to assess the prevalence of IFG, IGT, and pre-diabetes and used the log-binomial model to estimate the prevalence ratios (PRs) and 95% CIs. RESULTS—The unadjusted prevalences of IFG, IGT, and pre-diabetes were 13.1, 3.4, and 16.1%, respectively. Boys had a 2.4-fold higher prevalence of pre-diabetes than girls (95% CI 1.3–4.3). Non-Hispanic blacks had a lower rate than non-Hispanic whites (PR 0.6, 95% CI 0.4–0.9). Adolescents aged 16–19 years had a lower rate than those aged 12–15 years (0.6, 0.4–0.9). Overweight adolescents had a 2.6-fold higher rate than those with normal weight (1.3–5.1). Adolescents with two or more cardiometabolic risk factors had a 2.7-fold higher rate than those with none (1.5–4.8). Adolescents with hyperinsulinemia had a fourfold higher prevalence (2.2–7.4) than those without. Neither overweight nor number of cardiometabolic risk factors was significantly associated with pre-diabetes after adjustment for hyperinsulinemia. CONCLUSIONS—Pre-diabetes was highly prevalent among adolescents. Hyperinsulinemia was independently associated with pre-diabetes and may account for the association of overweight and clustering of cardiometabolic risk factors with pre-diabetes.

[1]  S. Daniels,et al.  Frequency of abnormal carbohydrate metabolism and diabetes in a population-based screening of adolescents. , 2005, The Journal of pediatrics.

[2]  Shumei S. Guo,et al.  2000 CDC Growth Charts for the United States: methods and development. , 2002, Vital and health statistics. Series 11, Data from the National Health Survey.

[3]  G. Reaven.  Banting lecture 1988. Role of insulin resistance in human disease. , 1988, Diabetes.

[4]  Pedagógia,et al.  Cross Sectional Study , 2019 .

[5]  V. Fonseca.  Early identification and treatment of insulin resistance: impact on subsequent prediabetes and type 2 diabetes. , 2007, Clinical cornerstone.

[6]  M R Petersen,et al.  Prevalence proportion ratios: estimation and hypothesis testing. , 1998, International journal of epidemiology.

[7]  R. Bergman,et al.  Impaired Glucose Tolerance and Reduced β-Cell Function in Overweight Latino Children with a Positive Family History for Type 2 Diabetes , 2004 .

[8]  Paul Zimmet,et al.  The metabolic syndrome—a new worldwide definition , 2005, The Lancet.

[9]  Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures. , 1994, Vital and health statistics. Ser. 1, Programs and collection procedures.

[10]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[11]  J M Dekker,et al.  Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. , 2001, JAMA.

[12]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[13]  M. Engelgau,et al.  Prevalence of Impaired Fasting Glucose and Its Relationship With Cardiovascular Disease Risk Factors in US Adolescents, 1999–2000 , 2005, Pediatrics.

[14]  A. Mazur,et al.  Prevalence of glucose intolerance in school age children. Population based cross‐sectional study , 2007, Acta paediatrica.

[15]  J. Shaw,et al.  Risk of Cardiovascular and All-Cause Mortality in Individuals With Diabetes Mellitus, Impaired Fasting Glucose, and Impaired Glucose Tolerance: The Australian Diabetes, Obesity, and Lifestyle Study (AusDiab) , 2007, Circulation.

[16]  A. Mokdad,et al.  Recent Trends in Waist Circumference and Waist-Height Ratio Among US Children and Adolescents , 2006, Pediatrics.

[17]  Shumei S. Guo,et al.  CDC GROWTH CHARTS FOR THE UNITED STATES: METHODS AND DEVELOPMENT 2000 , 2002 .

[18]  L. Gilardini,et al.  Prevalence and concomitants of glucose intolerance in European obese children and adolescents. , 2003, Diabetes care.

[19]  A. Grüters,et al.  Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity -- a problem that is no longer restricted to minority groups. , 2004, European journal of endocrinology.

[20]  P. O S I T I O N S T A T E M E N T,et al.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[21]  Sonia Caprio,et al.  Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning , 2003, The Lancet.

[22]  H. Woerle,et al.  Different Mechanisms for Impaired Fasting Glucose and Impaired Postprandial Glucose Tolerance in Humans A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances. , 2006, Diabetes Care.

[23]  T. Baranowski,et al.  Presence of diabetes risk factors in a large U.S. eighth-grade cohort. , 2006, Diabetes care.

[24]  W. Tamborlane,et al.  Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. , 2002, The New England journal of medicine.

[25]  Nicola J Cooper,et al.  Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis , 2007, BMJ : British Medical Journal.